1. Home
  2. TRDA vs UNTY Comparison

TRDA vs UNTY Comparison

Compare TRDA & UNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRDA

Entrada Therapeutics Inc.

HOLD

Current Price

$12.65

Market Cap

500.4M

Sector

Health Care

ML Signal

HOLD

Logo Unity Bancorp Inc.

UNTY

Unity Bancorp Inc.

HOLD

Current Price

$52.38

Market Cap

497.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRDA
UNTY
Founded
2016
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
500.4M
497.6M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
TRDA
UNTY
Price
$12.65
$52.38
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$21.00
$65.00
AVG Volume (30 Days)
144.6K
43.6K
Earning Date
05-08-2026
04-14-2026
Dividend Yield
N/A
1.22%
EPS Growth
N/A
39.66
EPS
N/A
5.67
Revenue
$25,421,000.00
N/A
Revenue This Year
$39.97
$12.14
Revenue Next Year
$50.80
$9.56
P/E Ratio
N/A
$9.26
Revenue Growth
N/A
N/A
52 Week Low
$4.93
$41.08
52 Week High
$14.49
$57.30

Technical Indicators

Market Signals
Indicator
TRDA
UNTY
Relative Strength Index (RSI) 46.56 46.93
Support Level $10.84 $50.48
Resistance Level $12.93 $53.61
Average True Range (ATR) 0.58 1.59
MACD -0.19 -0.31
Stochastic Oscillator 23.92 29.34

Price Performance

Historical Comparison
TRDA
UNTY

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About UNTY Unity Bancorp Inc.

Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. The Company has elected to become a financial holding company pursuant to regulations of the Board of Governors of the Federal Reserve System (the FRB). The Company's primary business is ownership and supervision of the Bank. The Company and the Bank derive a majority of their revenue from net interest income (i.e., the difference between the interest received on loans and securities and the interest paid on deposits and borrowings). The Company, through the Bank, conducts a traditional and community-oriented commercial banking business and services, personal and business checking accounts, time deposits, money market accounts, savings accounts, credit cards, automated teller service, and others.

Share on Social Networks: